Skip to content
10-Q

Quarterly Report

SPRING PHARMACEUTICAL GROUP, INC.

0001096906-18-000485

← back to feed
Filed
Aug 14, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Aug 14, 2018 29.84M sh
Capex Q1 2018 · Jun 30, 2018 $70.79K
Capex Q1 2018 · Jun 30, 2017 $2.08M
Cash And Equivalents Q1 2018 · Jun 30, 2018 $27.86M
Cash And Equivalents Q1 2018 · Mar 31, 2018 $25.35M
Cash And Equivalents Q1 2018 · Jun 30, 2017 $14.89M
Cash And Equivalents Q1 2018 · Mar 31, 2017 $10.31M
Stockholders Equity Q1 2018 · Jun 30, 2018 $104.26M
Stockholders Equity Q1 2018 · Mar 31, 2018 $105.11M
Current Liabilities Q1 2018 · Jun 30, 2018 $1.46M
Current Liabilities Q1 2018 · Mar 31, 2018 $1.98M
Current Assets Q1 2018 · Jun 30, 2018 $33.23M
Current Assets Q1 2018 · Mar 31, 2018 $30.07M
Total Assets Q1 2018 · Jun 30, 2018 $108.74M
Total Assets Q1 2018 · Mar 31, 2018 $110.14M
Sga Expense Q1 2018 · Jun 30, 2018 $1.08M
Sga Expense Q1 2018 · Jun 30, 2017 $908.41K
Rd Expense Q1 2018 · Jun 30, 2018 $322.73K
Rd Expense Q1 2018 · Jun 30, 2017 $64.38K
Net Income Q1 2018 · Jun 30, 2018 $4.63M
Net Income restated Q1 2018 · Jun 30, 2017 $3.93M
Operating Income Q1 2018 · Jun 30, 2018 $6.13M
Operating Income Q1 2018 · Jun 30, 2017 $4.64M
Gross Profit Q1 2018 · Jun 30, 2018 $8.92M
Gross Profit Q1 2018 · Jun 30, 2017 $6.85M
Cost Of Revenue Q1 2018 · Jun 30, 2018 $11.96M
Cost Of Revenue Q1 2018 · Jun 30, 2017 $10.29M
Revenue Q1 2018 · Jun 30, 2018 $20.89M
Revenue Q1 2018 · Jun 30, 2017 $17.13M